Thu, September 3, 2020
Wed, September 2, 2020
Tue, September 1, 2020

Matt Borsch Maintained (AMED) at Hold with Increased Target to $270 on, Sep 2nd, 2020

Matt Borsch of BMO Capital, Maintained "Amedisys, Inc." (AMED) at Hold with Increased Target from $250 to $270 on, Sep 2nd, 2020.

Matt has made no other calls on AMED in the last 4 months.



There are 5 other peers that have a rating on AMED. Out of the 5 peers that are also analyzing AMED, 1 agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Mok of "UBS" Maintained at Hold with Decreased Target to $190 on, Monday, May 11th, 2020


These are the ratings of the 4 analyists that currently disagree with Matt


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Increased Target to $250 on, Thursday, July 30th, 2020
  • Frank Morgan of "RBC Capital" Maintained at Buy with Increased Target to $260 on, Thursday, July 30th, 2020
  • John Ransom of "Raymond James" Maintained at Buy with Increased Target to $255 on, Thursday, July 30th, 2020
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $260 on, Thursday, July 30th, 2020